What's on Your Mind?

The streaming service branding game of musical chairs continued this week when Warner Bros. Discovery (WBD) announced the streaming platform Max would once again be called HBO Max, starting this summer. It’s a complete brand reversal from a switch the company made back in 2023, when it ditched the “HBO” in its name for a head scratching “Max.” It immediately brought to mind this joke from 2024: “It’s on Tubu. It’s literally on Heebee. It’s on Poodee with ads. It’s literally on Dippy. You can probably find it on Weeno. Dude it’s on Gumpy. It’s a Pheebo original. It’s on Poob. You can watch it on Poob. You can go to Poob and watch it. Log onto Poob right now.” https…

Heat pumps can reduce carbon emissions associated with heating buildings, and many states have set aggressive targets to increase their use in the coming decades. But while heat pumps are often cheaper choices for new buildings, getting homeowners to install them in existing homes isn’t so easy. Current energy prices, including the rising cost of electricity, mean that homeowners may experience higher heating bills by replacing their current heating systems with heat pumps—at least in some regions of the country. Heat pumps, which use electricity to move heat from the outside in, are used in only 14% of U.S. households. They are common primarily in warm southern s…

On the edge of Boulder, Colorado, a remarkable convergence of mutually beneficial collaboration is underway, and it could reshape how housing gets built, who builds it, and who is able to afford it. This is all happening inside BoulderMOD, a new modular housing factory built by the city of Boulder for use by the local Habitat for Humanity affiliate and powered by the labor of apprentice modular home builders from area public high schools. The students come to the factory several hours a day for hands-on education in advanced home building, working on actual modular homes that are now being installed in a section of Boulder devastated by flooding. At full capacity…

Working with AI as a team isn’t about knowing the latest technology. It’s about changing your mindset to build skills AI can’t replace, focusing on outcomes, not optics, and leaving room for strategic tests. View the full article

A college degree is usually thought of as a ticket to a great job and a secure future. Yet, the job market over the past few years has not been kind to graduates. Rapid changes in technology and uncertainty about the influence of AI on the economy have made it harder for companies to know what their new employees need to know to be successful. I have argued in the past that this uncertainty actually makes college degrees more useful than ever, but higher education is doing a poor job of helping students navigate this uncertainty. Sadly, universities aren’t going to fix this problem by hiring more career counselors. Instead, they’re going to have to do the hard work of…

There were a lot of smiling faces at the Oscars but one had to stand out—Sean Baker saw his film Anora go home with the top film prize and he took four for himself. Its star Mikey Madison was crowned best actress. Twenty-two years after winning best actor for The Pianist, Adrien Brody won the same Oscar again for his performance as another Holocaust survivor in Brady Corbet’s The Brutalist. He somehow kept the playoff music at bay. On Sunday, firefighters who battled recent wildfires got applauded, Mick Jagger handed out the best original song Oscar, and John Lithgow was tasked with looking “slightly disappointed” when speeches ran long. One highlight was Timothée Chala…

This Oscar cycle’s heavyweight battle is finally over. The politically charged action comedy “One Battle After Another” just managed to outmuscle Ryan Coogler’s musically driven vampire thriller “Sinners.” It was a 3 hour and 40 minute whirl through cinema and celebration, with Michael B. Jordan winning best actor for “Sinners” and Jessie Buckley winning for “Hamnet,” making her the first Irish performer to ever win in the category. There was electricity when Autumn Durald Arkapaw became the first woman and Black person to win the cinematography award for “Sinners,” asking all the women in the Dolby Theatre to stand up because moments like this don’t happen without wome…

Telehealth company Hims & Hers Health is fighting back after the drug industry’s main lobbying group called out its first Super Bowl ad as “misleading” and in potential violation of marketing rules. The ad is a one-minute spot set to Childish Gambino’s “This is America,” which admonishes the U.S.’s “broken” weight-loss business and instead offers up its “affordable, doctor-trusted” copycat weight-loss drugs. The lobbying group, Pharmaceutical Research and Manufacturers of America, said Thursday the ad was “a clear violation” of the Federal Food, Drug, and Cosmetic Act and “misrepresents the safety and efficacy of their knockoff GLP-1 medicines.” Hims &…

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug and one day after the Food and Drug Administration threatened to restrict access to the ingredients needed to copy popular weight-loss medications. Hims had said Thursday that it would offer a compounded version of the new Wegovy pill that drugmaker Novo Nordisk just began selling last month. Novo immediately threatened to sue Hims, and then the FDA said Friday that it plans to take decisive steps to limit access to the active ingredients in popular GLP-1 drugs like Wegovy, Ozempic and Zepbound. Hims’ own w…

Shares in Hims & Hers Health (NYSE: HIMS) are soaring this morning after an unconfirmed report that the telehealth company is entering into a deal with Novo Nordisk A/S (NYSE: NVO) to sell its popular GLP-1 weight-loss drugs, including Wegovy. The rumored deal is as surprising as Hims & Hers’s surging stock price this morning, especially considering that just last month, Novo was threatening to sue the telehealth provider. Here’s what you need to know. What’s happened? Late on Friday, Bloomberg reported that Hims & Hers has reached an agreement with the Danish drugmaker Novo Nordisk to sell Novo’s weight-loss drugs, including the popular GLP-1 pill…

Shares in Hims & Hers Health, Inc. (NYSE: HIMS) are skyrocketing in early-morning trading today after the telehealth company announced a new partnership with the Danish pharmaceutical giant Novo Nordisk. That partnership will see Hims & Hers offer Novo Nordisk’s weight-loss drug Wegovy through its platform. Here’s what you need to know. Hims & Hers will offer weight-loss drug Wegovy Hims & Hers Health announced today that it has entered into “a long-term collaboration” with Danish drugmaker Novo Nordisk to offer its popular weight-loss drug Wegovy to its users through the Hims & Hers platform. The news sent HIMS shares soaring in early-morn…

Amid a month of skyrocketing stock prices and unprecedented social media buzz, Hims & Hers is expanding its territory into at-home blood testing and diagnostics. Hims has acquired at-home lab testing facility Trybe Labs, the telehealth company said Wednesday. Using at-home blood draws, Hims will now offer over 70 at-home diagnostics tests, ranging from heart health to certain cancer detection tests. All these can be arranged through the app, without a doctor’s visit. “At-home lab testing is one more exciting step towards elevating the personal, comprehensive care customers in this country should expect,” Dr. Patrick Carroll, Hims & Hers chief medical o…

Hinge Health Inc, the digital physical therapy health startup that is expected to make its market debut on Thursday, in a closely watched initial public offering (IPO) that will test the market’s interest for a new digital health offering, after what has been a challenging few years for the sector. Recently, there have been fewer tech IPOs, but they could be making a comeback, according to CNBC. The San Francisco-based company priced shares at $32 on Wednesday, the higher end of its expected range, in an offering led by Morgan Stanley, Barclays, and BofA Securities. The stock will list on the New York Stock Exchange (NYSE) under the “HNGE” ticker symbol. Bas…

There was a time when artists representing two of America’s biggest homegrown musical genres wouldn’t get a look in at the Grammys. Hip-hop and house both have their origins in the 1970s and early 1980s—in fact, they recently celebrated a 50th and 40th birthday, respectively. But it was only in 1989 that an award category for “best rap performance” started recognizing hip-hop’s contribution to U.S. music, and house had to wait another decade, with the introduction of “best dance/electronic recording” in 1998. At this year’s awards, taking place on February 2, hip-hop and house artists will be among the most talked about. House duo Justice and Kendrick Lamar, a hip…

Hiroshi Fujiwara is perhaps the most dramatically lit person I’ve ever interviewed on Zoom. Joining me at his preferred time (midnight) from Tokyo, the man known as the godfather of streetwear—who launched his own label at 26, was among the first hip-hop DJs in Japan, wrote a regular column for Popeye, and now runs his own consultancy, Fragment—has met with me to discuss his latest collaborations with Nike. But when I dig in, asking about the hidden details lurking in his shoes? He admits, “I don’t really want to talk about it,” without an ounce of rudeness. “Sometimes, if you see a movie and you don’t really get the ending, you have to guess what [the creators] t…

Hit-Boy has made chart-topping beats for the likes of Beyoncé, Jay Z, Nas and Doechii but behind the scenes he was stuck in a restrictive publishing deal. In this interview, Hit-Boy talks But now he’s in full control of his art and his story. He’ll also dive into his creative process and how he’s walking the line of AI and art. View the full article